New York, NY -- (SBWIRE) -- 12/13/2013 -- StockMarketIntel.com issues a special report on the following stocks: BASF SE (ADR) (OTCMKTS:BASFY), Dynavax Technologies Corporation (NASDAQ:DVAX), Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB), LVMH Moet Hennessy Louis Vuitton SA(ADR) (OTCMKTS:LVMUY)
BASF SE (ADR) (OTCMKTS:BASFY) declined -0.40%, trading on 38,544 shares, to end the trade at $101.38. If we look at its trading history of the past 52 weeks, the share price suffered a low of $85.24 and was moved to the maximum level of $107.45. The stock changed hands in a range of $101.21 to $102.00, bringing its market capitalization to about $93.12 billion. BASF SE operates as a chemical company worldwide. The company?s Chemicals segment provides basic chemicals, glues, and electronic chemicals for the semiconductor and solar cell industries; solvents and plasticizers; and starting materials for detergents, plastics, textile fibers, paints and coatings, crop protection products, and pharmaceuticals
Will BASFY Get Buyers Even After The Recent Rally? Find Out Here
Dynavax Technologies Corporation (NASDAQ:DVAX) added 1.83%, to complete the trading session at $1.67, with a total volume of 4.09 million shares. The stock, on average, trades on a volume of 5.04 million shares. In the past 52 weeks, the share price has not declined below $0.98 and above $3.39. It floated in a range of $1.61 to $1.71 during the last trading session, with a beta value of 2.75. Its market capitalization now moved to about $438.58 million. Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. It develops product candidates based on the use of immunostimulatory sequences and immunoregulatory sequences.
What was the Moving Force behind DVAX on Bullish Run? Read This Research Report
Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) recorded a fall of -1.96% and was in a range of $1.99-$2.09 before closing at $2.00. The share price hit its 52-week low of $1.11 and $3.59 was the best price. The stock completed the day with a total volume of 1.69 million shares, versus an average volume of 1.75 million shares. Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents.
Will NAVB Bounce Back After yesterday’s Sharp Sell off? Find Out Here
LVMH Moet Hennessy Louis Vuitton SA(ADR) (OTCMKTS:LVMUY) declined -1.13% yesterday, bringing its market capitalization around $87.85 billion. The total number of shares that changed hands during the session was 60,464 shares, as compared to average trading volume of 103,501 shares. The share price, after opening at $35.12, made a high of $35.21 and hovered above $34.97 to end the day at $35.10. LVMH Moët Hennessy - Louis Vuitton SA engages in the manufacture and sale of luxury products. The company operates through Wines and Spirits, Fashion and Leather Goods, Perfumes and Cosmetics, Watches and Jewelry, and Selective Retailing business groups.
Is it the Right to Grab LVMUY after the Recent Slump? Get Free Trend Analysis Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)